652 Results

People

  1. Fong
    Fong
  2. Jarnagin
    Jarnagin
  3. Kemeny
    Kemeny
  4. D'Angelica
    D'Angelica
  5. Blumgart
    Blumgart
  6. DeMatteo
    DeMatteo
  7. Gonen
    Gonen
  8. Cohen
    Cohen
  9. Allen
    Allen
  10. Paty
    Paty

Groups

  1. Department of Medicine (282)
  2. Solid Tumor Oncology Division (267)
  3. Surgery (255)
  4. Center for Pancreatic Cancer Research (197)
  5. Gastrointestinal Oncology Service (168)
  6. Radiology, Department of (116)
  7. Epidemiology and Biostatistics (84)
  8. Biostatistics Service (81)
  9. GSK Faculty (79)
  10. Department of Pathology and Laboratory Medicine (67)
  1. "liver metastasis"
Formats
  1. Journal Article (596)
  2. Review (21)
  3. Editorial (13)
  4. Conference Paper (11)
  5. Correspondence (3)
  6. Meeting Abstract (2)
  7. Miscellaneous (2)
  8. Research Letter (2)
  9. Book Section (1)
  10. Guidelines (1)
Groups
  1. Department of Medicine (282)
  2. Solid Tumor Oncology Division (267)
  3. Surgery (255)
  4. Center for Pancreatic Cancer Research (197)
  5. Gastrointestinal Oncology Service (168)
  6. Radiology, Department of (116)

More Groups

People
  1. Yuman Fong (117)
  2. Nancy Kemeny (111)
  3. William Jarnagin (92)
  4. Michael D'Angelica (69)
  5. Leslie Blumgart (65)
  6. Ronald DeMatteo (65)

More People

Years
  1. 2025 (24)
  2. 2024 (42)
  3. 2023 (29)
  4. 2022 (19)
  5. 2021 (12)
  6. 2020 (17)

More Years

Publications
  1. Annals of Surgical Oncology (45)
  2. Cancer (34)
  3. Journal of Clinical Oncology (29)
  4. Annals of Surgery (23)
  5. Journal of Surgical Oncology (15)
  6. Journal of the American College of Surgeons (14)

More Publications

Publishers
  1. Elsevier Inc. (106)
  2. Springer (88)
  3. Wiley Blackwell (59)
  4. Lippincott Williams & Wilkins (57)
  5. Elsevier Science, Inc. (51)
  6. American Society of Clinical Oncology (31)

More Publishers

Results (652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Staged or simultaneous surgery for colon or rectal cancer with synchronous liver metastases: Implications for study design and clinical endpoints
    Editorial

    Yaqub, S.; Margonis, G. A.; Søreide, K.
    Cancers (2023)

    Fulltext@MSK | Save
  • Neuroendocrine tumor therapy response assessment
    Review

    Jayaprakasam, V. S.; Bodei, L.
    PET Clinics (2023)

    Fulltext@MSK | Save
  • Near-infrared fluorescence imaging for detecting pancreatic liver metastasis in an orthotopic athymic mouse model
    Journal Article

    Lee, L. D.; Hering, N. A.; Zibell, M.; Lobbes, L. A.; Kamphues, C.; Lauscher, J. C.; Margonis, G. A.; Seeliger, H.; Beyer, K.; Weixler, B.; more...
    In Vivo (2023)

    Fulltext@MSK | Save
  • Commentary: Closing the curtain on upfront surgery for esophageal squamous cell carcinoma
    Editorial

    Fairbairn, K.; Molena, D.
    Journal of Thoracic and Cardiovascular Surgery (2023)

    Fulltext@MSK | Save
  • Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database
    Journal Article

    Margalit, O.; Harmsen, W. S.; Shacham-Shmueli, E.; Voss, M. M.; Boursi, B.; Wagner, A. D.; Cohen, R.; Olswold, C. L.; Saltz, L. B.; Goldstein, D. A.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy
    Journal Article

    Dercle, L.; Ammari, S.; Roblin, E.; Bigorgne, A.; Champiat, S.; Taihi, L.; Plaian, A.; Hans, S.; Lakiss, S.; Tselikas, L.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • ASO Author Reflections: Ras-p53 cooperativity predicts recurrence patterns after resection of colorectal liver metastases with adjuvant local and systemic chemotherapy
    Editorial

    Narayan, R. R.; Datta, J.; D’Angelica, M. I.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer
    Journal Article

    Kim, D. W.; Kim, Y. C.; Kovari, B. P.; Chung, V.; Alese, O. B.; El-Rayes, B. F.; Li, D.; Park, W.; Kim, R. D.
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Advances in the management of liver and biliary tumors
    Review

    Jarnagin, W. R.; D'Angelica, M. I.
    Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Telaglenastat plus everolimus in advanced renal cell carcinoma: A randomized, double-blinded, placebo-controlled, phase II ENTRATA trial
    Journal Article

    Lee, C. H.; Motzer, R.; Emamekhoo, H.; Matrana, M.; Percent, I.; Hsieh, J. J.; Hussain, A.; Vaishampayan, U.; Liu, S.; McCune, S.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save